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RESEARCH
Quantitative phosphoproteomic analysis 
reveals reciprocal activation of receptor 
tyrosine kinases between cancer epithelial cells 
and stromal fibroblasts
Xinyan Wu1,2,8*†, Muhammad Saddiq Zahari1,2†, Santosh Renuse1,2,3†, Nandini A. Sahasrabuddhe1,2,3,4, 
Raghothama Chaerkady1,2, Min‑Sik Kim1,2, Mary Jo Fackler5, Martha Stampfer7, Edward Gabrielson5,6, 
Saraswati Sukumar5 and Akhilesh Pandey1,2,3,8* 
Abstract 
Background: Cancer‑associated fibroblasts (CAFs) are one of the most important components of tumor stroma and 
play a key role in modulating tumor growth. However, a mechanistic understanding of how CAFs communicate with 
tumor cells to promote their proliferation and invasion is far from complete. A major reason for this is that most cur‑
rent techniques and model systems do not capture the complexity of signal transduction that occurs between CAFs 
and tumor cells.
Methods: In this study, we employed a stable isotope labeling with amino acids in cell culture (SILAC) strategy to 
label invasive breast cancer cells, MDA‑MB‑231, and breast cancer patient‑derived CAF this has already been defined 
above cells. We used an antibody‑based phosphotyrosine peptide enrichment method coupled to LC–MS/MS to 
catalog and quantify tyrosine phosphorylation‑mediated signal transduction events induced by the bidirectional 
communication between patient‑derived CAFs and tumor cells.
Results: We discovered that distinct signaling events were activated in CAFs and in tumor epithelial cells during the 
crosstalk between these two cell types. We identified reciprocal activation of a number of receptor tyrosine kinases 
including EGFR, FGFR1 and EPHA2 induced by this bidirectional communication.
Conclusions: Our study not only provides insights into the mechanisms of the interaction between CAFs and tumor 
cells, but the model system described here could be used as a prototype for analysis of intercellular communication in 
many different tumor microenvironments.
Keywords: Breast cancer, Epithelial cell, Carcinoma‑associated fibroblast, Signaling crosstalk, SILAC, 
Phosphoproteome, Mass spectrometry, Co‑culture
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Background
An intrinsic feature of cancers is the presence of a stro-
mal compartment that generally provides a supportive 
microenvironment for tumor epithelial cells. It is becom-
ing increasingly clear that malignant cells themselves 
are not sufficient to maintain tumor growth and pro-
gression and that the tumor stroma plays an essential 
role in this process [1, 2]. As a major component of the 
stromal compartment in tumors, fibroblasts can be acti-
vated and acquire a modified phenotype similar to fibro-
blasts associated with wound healing [1]. These activated 
cancer-associated fibroblasts (CAFs) are a major source 
of paracrine growth factors, including bFGF, HGF, and 
TGF-β, that can further promote the growth of carcino-
mas and recruit endothelial cells for angiogenic processes 
[1, 2].
It has been shown that CAFs isolated from various can-
cers, including breast, ovarian and prostate cancers, are 
more competent than normal fibroblasts in enhancing 
tumor growth [3]. CAFs have also been shown to pro-
mote genomic instability, induce epithelial-mesenchymal 
transition, and promote tumor growth and angiogenesis 
[4, 5]. Further, studies of bone marrow-derived tumor 
stromal cells have demonstrated that they are critical in 
creating pre-metastatic niches to facilitate the formation 
of metastases [6, 7]. These findings confirm that CAFs 
indeed have properties that are distinguishable from 
normal fibroblasts and are intimately involved in almost 
every step of tumor progression, from initiation to 
metastasis. The crucial role of fibroblasts in tumor devel-
opment was recently demonstrated by a study showing 
that a signature derived from gene expression profiling 
of microdissected stroma from primary tumors, termed 
“stroma-derived prognostic predictor” (SDPP), could be 
used as a robust and accurate tool in predicting breast 
cancer prognosis [8]. Notably, this signature had an even 
higher accuracy than all other current mRNA-based 
profiles for prediction purposes, independent of clinical 
breast cancer subtypes such as ER and HER2 status [8]. 
One possible reason for such accuracy is that alterations 
in fibroblasts might be more uniform than those in carci-
noma cells. Unlike the heterogeneous genomic and epi-
genetic alterations observed in breast cancer cells, which 
makes treatment of breast cancer challenging, the rela-
tive molecular uniformity of CAFs may lend itself to the 
development of optimal therapies for the prevention of 
metastasis.
Nevertheless, in order to target CAFs for cancer ther-
apy, two major questions remain to be answered: What 
are the events that occur during conversion of normal 
fibroblasts to CAFs and what are the key mechanisms of 
interaction between CAFs and tumor cells that promote 
tumor aggressiveness. One approach to studying these 
interactions is by analyzing the conditioned media from 
cultured CAFs; indeed, growth factor-induced paracrine 
communication has been identified as one of the major 
mechanisms mediating the crosstalk between tumor 
cells and CAFs [4, 9, 10]. However, given that tumor 
cells physically and persistently interact with stromal 
cells in  vivo, more complex communication events take 
place than those initiated by the soluble factors secreted 
into the extracellular environment. To this end, 2D and 
3D co-culture systems have been developed to simulate 
the in vivo tumor microenvironment. However, conven-
tional molecular biology approaches are not capable of 
discriminating whether the source of proteins is from the 
epithelial tumor cells or CAFs when they are co-cultured 
and processed together. This significantly limits their util-
ity for systematic analysis of the true crosstalk between 
tumor epithelium and CAFs.
A mass spectrometry-based quantitative proteomic 
method, stable isotope labeling by amino acids in cell 
culture (SILAC), is an approach that utilizes amino acids 
with substituted stable isotopic nuclei to metabolically 
label whole cellular proteomes during cell culture [11–
13]. Using this strategy, we can label the entire proteomes 
of different cells with stable isotope-containing amino 
acids, culture the cells together and still be able to dis-
tinguish the specific cellular source of proteins. SILAC 
labeling strategy has been used to identify bidirectional 
cell-specific signaling events initiated between HEK293 
cells either expressing the Eph receptor, EPHB2 or its 
transmembrane ephrin ligand, ephrin-B1 [14]. More 
recently, this strategy was also employed to study the 
signaling crosstalk between MDA-MB-231 and human 
umbilical vein endothelial cells [15]. In additional to the 
classic SILAC based labeling strategy, another alterna-
tive cell-specific isotopic labeling technology, named 
cell-type-specific labeling with amino acid precursors has 
been developed [16] and used to study long-term sign-
aling crosstalk between a human breast cancer cell line 
MDA-MB-231 and a mouse embryo fibroblast cell line, 
C3H/10T1/2 [17].
In this study, we employed the SILAC labeling strategy 
to differentially label a highly aggressive triple negative 
breast cancer cell line, MDA-MB-231 and a primary cul-
tured human breast CAF (82T) during a short-term co-
culture. Using antibody-based tyrosine phosphopeptide 
enrichment coupled with high-resolution and high-accu-
racy mass spectrometry, we systematically quantified 
the bidirectional phosphotyrosine proteome changes 
induced by the interaction of epithelial tumor cells and 
CAFs. We found differential activation of a number of 
tyrosine kinases when tumor cells were co-cultured with 
primary breast CAFs indicating that there are distinct 
signaling events occurring in epithelial tumor cells and in 
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CAFs during such interactions that could play important 
roles in tumor development.
Methods
Cell culture and reagent
MDA-MB-231 cells were purchased from ATCC. Eight 
breast cancer associated fibroblast cell strains, 76T (p9), 
72T (p7), 8T (p7), 85T (p5), 35T (p6), 84T (p6), 82T (p6) 
and 120T (p8) were generated by one of us (MS). MDA-
MB-231 and all eight CAFs cell strains were cultured 
in DMEM-F12 medium supplemented with 5% FBS or 
10% FBS, respectively. All cells were grown in 5%  CO2 at 
37 °C. DMEM-F12 with and without Lysine and Arginine, 
fetal bovine serum (FBS), l-glutamine, and antibiotics 
were purchased from Invitrogen (Carlsbad, CA). SILAC 
amino acids, 2H4-Lys and 13C6-Arg and heavy amino 
acids, 13C615N2-Lys and 13C615N4-Arg were purchased from 
Cambridge Isotope Laboratories (Andover, MA). (Ando-
ver, MA). Anti-phosphotyrosine mouse mAb (pTyr-100) 
beads were purchased from Cell Signaling Technology 
(Danvers, MA). TPCK-treated trypsin was obtained from 
Worthington Biochemical Corp. (Lakewood, NJ). All 
other reagents used in this study were from Fisher Scien-
tific (Pittsburgh, PA).
Retroviral and lentiviral production and cell infection
Retroviral expression plasmid, pKMRV-EGFP was co-
transfected with the packaging vector, pCL-Ampho into 
HEK293T cells. Lentiviral plasmid expressing tdTomato 
Red, pFUtdTW (Addgene) was co-transfected with the 
helper plasmid pHR’8.2delta and the envelop plasmid, 
pCMV-VSV-G into HEK293T cells. Transfection is medi-
ated by Lipofectamine 2000. pKMRV-EGFP and pFUt-
dTW viral supernatants were collected at 24, 48 and 
72 h post transfection and used to infect 82T and MDA-
MB-231 cells, respectively. Infected cells with strong 
expression of GFP or tdTomato Red were sorted using 
flow cytometry and expanded in cell culture for co-cul-
ture analysis.
Cell proliferation analysis
A commonly used cell proliferation assay employing 
crystal violet dye [18, 19] was used to evaluate the cell 
growth rate for 8 CAFs. Briefly, 10,000 cells were seeded 
in each well of 24-well plates and cultured for 7  days. 
Cells were fixed and stained with 0.05% crystal violet in 
4% formalin. Crystal violet dye in stained cells was then 
eluted with 0.4% acetic acid and measure at O.D. 595. To 
examine the cell growth in co-culture system, 82T CAFs 
or MDA-MB-231 breast cancer cells labeled with EGFP 
or tdTomato Red were seeded separately or in combi-
nation into each well of 96-well culture dishes and cul-
tured in DMEM-F12 with 5% FBS. After 5  day, EGFP 
or tdTomato Red fluorescence was measured using a 
POLARstar Omega microplate plate reader.
Soft agar colony formation analysis
Agar (0.5% bottom layer) was prepared in 6-well plates. 
Five hundred 82T or MDA-MB-231 cells were, separately 
or in combination, mixed with 0.35% agar in 1 × DMEM-
F12 medium supplemented with 5% FBS and seeded on 
top of bottom layer agar. 1  ml of DMEM-F12 medium 
with 5% FBS was added in each well. Cells were grown for 
14 days at 37 °C. Colonies were then stained with crystal 
violet and counted under the microscope. Colonies with 
size of more than 50 cells were counted.
Immunoblot analysis
Individually cultured and co-cultured cells were har-
vested and lysed in modified RIPA buffer (50 mM Tris–
HCl, pH 7.4, 150  mM NaCl, 1  mm EDTA, 1% Nonidet 
P-40, 0.25% sodium deoxycholate, and 1  mM sodium 
orthovanadate in the presence of protease inhibitors). 
80  µg protein lysates were denatured and separated in 
NuPAGE gels (Invitrogen), transferred to nitrocellulose 
membranes and probed with HRP conjugated pY100 
antibody (Cell Signaling Technology).
Cell line SILAC labeling
Only non-transduced MDA-MB-231 and 82T cells were 
used for SILAC labeling and phosphoproteomics analy-
sis. Three-state stable isotopic labeling by amino acids in 
cell culture (SILAC) of MDA-MB-231 and 82T was per-
formed as described earlier [12, 20]. Briefly, to facilitate 
the incorporation of medium and heavy labels for MDA-
MB-231 cells, MDA-MB-231 were cultured in DMEM-
F12 SILAC labeling media supplemented with medium 
(2H4-Lys and 13C6-Arg) or heavy amino acids (13C615N2-
Lys and 13C615N4-Arg). To facilitate the incorporation of 
light and heavy labels of 82T cells, the CAFs were cul-
tured in DMEM-F12 media with light amino acids or 
heavy amino acids (13C615N2-Lys and 13C615N4-Arg). To 
achieve > 95% labeling efficiency, cells were cultured in 
corresponding SILAC media for at least 5 passages and 
labeling efficiency was assessed by LC–MS/MS analysis 
before any proteomics analysis.
SILAC labeled CAFs and MDA‑MB‑231 co‑culture
Nine million medium or heavy labeled MDA-MB-231 
cells were seeded into each of 15  cm culture dish and 
cultured in corresponding SILAC media overnight. Next 
day, light or heavy labeled 82T cells were treated with 
4 ml enzyme free Cell Dissociation Buffer (Invitrogen) to 
detach and dissociate cells. Cells were washed with cold 
PBS for three times and re-suspended in corresponding 
light or heavy DMEM-F12 SILAC media with 5% FBS. 9 
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million light labeled 82-L cells were seeded onto the plate 
with the pre-seeded medium labeled MDA-MB-231-M 
cells which were prewashed with cold PBS. The mixed 
cells were kept in heavy DMEM-F12 SILAC media with 
5% FBS at 37 °C for 30 min. 9 million heavy labeled 82T-H 
cells were seeded onto new 15 cm culture dish in heavy 
SILAC media with 5% FBS at 37 °C for 30 min. In order 
to keep the individually cultured epithelial cells, MDA-
MB-231 under the same treatment conditions, medium 
labeled MDA-MB-231 cells were also washed with cold 
PBS and incubated in SILAC DMEM-F12 medium media 
with 5% FBS at 37 °C for 30 min. These individually cul-
tured heavy labeled MDA-MB-231-H and 82T-H cells 
served as reference controls for co-cultured MDA-MB-
231-M cells and 82T-L cells. 82T cells attached during 
the 30 min of incubation. Both individually cultured and 
co-cultured cells were quickly washed with cold PBS once 
and harvested with 9 M urea lysis buffer (20 mM HEPES 
pH 8.0, 9 M urea, 1 mM sodium orthovanadate, 2.5 mM 
sodium pyrophosphate, 1  mM ß-glycerophosphate and 
5 mM sodium fluoride).
In‑solution trypsin digestion
After cells were harvested using urea lysis buffer, lysates 
from co-cultured 82T-L and MDA-MB-231-M cells were 
mixed with lysates from individually cultured 82T-H cells 
or MDA-MB-231-H cells. After mixing, cell lysates were 
sonicated and then cleared by centrifugation at 3000×g at 
4 °C for 10 min. As determined by BCA assay, 30 mg pro-
tein from mixed cell lysates was then reduced with 5 mM 
dithiothreitol and alkylated with 10 mM iodoacetamide. 
For in-solution tryptic digestion, 20 mM HEPES pH 8.0 
was used to dilute the mixed cell lysates to the final con-
centration of urea lower than 2 M. The diluted cell lysates 
were then digested with 1 mg/mL TPCK-treated trypsin 
on an orbital shaker at 25 °C overnight. Tryptic peptides 
were acidified with 1% trifluoroacetic acid (TFA) and 
desalted using SepPak  C18 cartridge. Eluted peptides 
were lyophilized to dryness prior to phosphotyrosine 
peptide enrichment.
Immunoaffinity purification of phosphotyrosine peptides
Immunoaffinity purification (IAP) of phosphotyrosine 
peptides was performed as described [21]. Briefly, fol-
lowing lyophilization, desalted lyophilized tryptic pep-
tides were reconstituted in 1.4 mL of IAP buffer (50 mM 
MOPS pH 7.2, 10 mM sodium phosphate, 50 mM NaCl). 
The reconstituted peptide mixtures were then incubated 
with anti-phosphotyrosine antibody beads (pY100, Cell 
Signaling Technology) on a rotator at 4  °C for 30  min. 
After incubation, phosphotyrosine peptides and the 
pY100 antibody complex were washed thrice with IAP 
buffer and then twice with water. Residual water was 
removed completely. Phosphopeptides were eluted from 
the antibody beads by acidifying the bead mixture at 
room temperature with 0.1% TFA. Phosphopeptides elu-
ents were desalted with  C18 STAGE tips, vacuum dried 
and stored at − 80 °C prior to LC–MS/MS analysis.
Liquid chromatography tandem mass spectrometry
Data dependent LC–MS/MS analysis of phosphopeptides 
enriched by IAP was performed with an LTQ-Orbitrap 
Velos mass spectrometer (Thermo Fisher Scientific) cou-
pled to a nano-liquid chromatography system (Proxeon, 
Easy Nano-LC). During each LC–MS/MS run, 1  μL of 
reconstituted peptide solution were injected onto a nano-
C18 reversed phase column (10  cm × 75  µm, Magic  C18 
AQ 5 µm, 120 Å). Peptides were than fractionated across 
a 90-min linear reversed phase HPLC gradient (from 5 
to 60% Acetonitrile). High-resolution precursor scans 
(FTMS) were acquired within the Orbitrap analyzer 
across a mass range of 350–1700 Da (with 60,000 resolu-
tion at 400 m/z). The ten most abundant precursor ions 
from each precursor scan were selected for high energy 
collision dissociation fragmentation (isolation width of 
1.90 m/z; 35% normalized collision energy and activation 
time of 0.1  ms). High-resolution MS/MS spectra were 
acquired (at 15,000 resolution at 400 m/z) on the Orbit-
rap analyzer following fragmentation.
Mass spectrometry data analysis
Proteome Discoverer (v2.0; Thermo Fisher Scientific) 
software package was used to facilitate downstream pro-
tein identification and quantitation. All acquired mass 
spectrometric data were searched within the Proteome 
Discoverer interface using the SEQUEST search algo-
rithm against Human RefSeq database v 69 (containing 
33,249 entries). The search parameters were as follows: 
a maximum of one missed cleavage; a fixed modifica-
tion of carbamidomethylation; variable modifications of 
N-terminal acetylation, oxidation at methionine, phos-
phorylation at serine, threonine and tyrosine and SILAC 
labeling 13C6,15N2-lysine; 2H4-lysine; 13C6-arginine and 
13C6,15N2-arginine; MS tolerance of ± 10  ppm; MS/MS 
tolerance of ± 0.1 Da. The SEQUEST score cut-offs were 
set to a false discovery rate of 1% at the peptide level. The 
probability that an identified phosphorylation was modi-
fying each specific Ser/Thr/Tyr residue on each identified 
phosphopeptide was determined from the PhosphoRS 
algorithm [22]. We averaged the intensities of the phos-
phopeptides identified in the two biological replicate 
experiments that were carried out. A twofold cut-off 
was selected for hyperphosphorylation and a 0.5-fold 
cut-off was selected to denote hypophosphorylation. All 
mass spectrometry proteomics data associated with this 
project have been deposited to the ProteomeXchange 
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Consortium (http://prote omece ntral .prote omexc hange 
.org) via the PRIDE partner repository with the dataset 
identifier PXD003544.
Results
Culture of primary tumor derived cancer associated 
fibroblasts
In order to investigate the crosstalk between epithelial 
tumor cells and CAFs, we used eight primary cultured 
CAF cell strains with early passage numbers (5–9 pas-
sages). To identify a CAF that can be efficiently SILAC 
labeled and can be propagated into large-scale cell cul-
ture for phosphoproteomic analysis, the growth rate of all 
eight CAFs was evaluated based on the cell proliferation. 
CAFs were cultured in 24-well dishes in DMEM/F12 
medium supplemented with 10% FBS for 7 days. Crystal 
violet staining was performed to measure the prolifera-
tion rate of each CAF. As shown in Fig. 1a, of the eight 
CAFs tested, 82T and 120T CAF cells grew at a relatively 
faster rate and 82T had a lower passage number (p6) 
compared to 120T (p8). Thus, we selected 82T for this 
study.
Co‑culture of breast cancer cell line with CAFs
A highly aggressive triple negative breast cancer cell 
line, MDA-MB-231, was selected as the tumor epithe-
lial counterpart of the CAFs. In order to differentially 
visualize the tumor epithelial cells and CAFs in the co-
culture system, we labeled 82T cells with EGFP and 
MDA-MB-231 with dtTomato red fluorescence protein 
using retroviral or lentiviral infection. Equal number of 
fluorescently labeled cells were mixed and co-cultured 
for 5 days (Fig. 1b). The green and red fluorescence inten-
sities were measured for 82T and MDA-MB-231 cells, 
respectively. The green and red fluorescence intensities of 
co-cultured MDA-MB-231 and 82T cells were compared 
to individually cultured MDA-MB-231 and 82T cells. 
Interestingly, we found co-culture with 82T increased the 
growth of MDA-MB-231 by about 25% (p = 0.03) com-
pared to individually co-cultured MDA-MB-231 (Fig. 1c). 
However, no significant growth difference was observed 
between individually cultured and co-cultured 82T cells. 
We also evaluated the anchorage independent growth of 
MDA-MB-231 cells with or without 82T cells co-culture 
using soft agar colony formation assays. We observed 
that MDA-MB-231 cells co-cultured with 82T not only 
had significantly more colonies (Fig. 1d, e) but the colo-
nies were also distinctly bigger compared to individually 
cultured MDA-MB-231 cells. These results are in line 
with previous reports that CAFs enhance the aggressive-
ness of epithelial tumor cells [23, 24].
It has been well accepted that paracrine signal-
ing occurs between tumor epithelium and stromal 
fibroblasts. Growth factors secreted by tumor cells and/
or CAFs can activate their receptor tyrosine kinases on 
recipient cells and initiate downstream signaling cas-
cades. In order to investigate the tyrosine phospho-
rylation levels in cells with or without co-culture, we 
performed western blot analysis using an anti-phospho-
tyrosine antibody, which revealed that the global tyros-
ine phosphorylation patterns between co-cultured cells 
(Lane 4) and individually cultured cells (Lane 1 and 2) or 
individually cultured cells mixed after lysis (Lane 3) were 
largely similar (Fig.  1f ). However, we observed several 
proteins whose tyrosine phosphorylation level was sub-
stantially increased due to co-culture (Fig. 1f indicated by 
arrows). Nevertheless, with classical western blot analy-
sis, we could not determine the identity of these proteins 
and whether they were from the tumor epithelium or 
CAFs. In order to comprehensively decipher these signal-
ing events, we decided to employ a SILAC labeled co-cul-
ture strategy for quantitative phosphoproteomic analysis 
(Fig. 2).
SILAC labeling‑based co‑culture system
To identify protein phosphorylation-based signal trans-
ductions in tumor epithelium and CAFs when they are 
in contact, we incorporated SILAC labeling technology 
into the co-culture system (Fig. 2). A three-state SILAC 
labeling strategy was used as shown in Fig. 2. After com-
plete labeling was achieved, we seeded medium-labeled 
MDA-MB-231-M on each tissue culture dish 8 h before 
co-culture, and an equal number of heavy-labeled MDA-
MB-231-H were also seeded at the same time to serve as 
the individually cultured control. We detached 82T cells 
with enzyme free cell dissociation buffer to avoid trypsin 
digestion that can cleave cell surface proteins. Light-
labeled 82T-L cells were seeded on each plate that had 
been pre-seeded with an equal number of MDA-MB-
231cells. In order to detect early phosphorylation signal-
ing events in co-cultured CAFs and breast cancer cells, 
we optimized the co-culture time and selected a short 
period of 30 min for co-culture in which CAF cells could 
completely settle on the plates. In parallel, heavy labeled 
82T-H cells were plated and allowed to settle for 30 min, 
and these 82T-H cells were used as individually cultured 
controls. After 30 min of co-culture, the cells were har-
vested for mass spectrometry-based quantitative phos-
photyrosine proteomic analysis.
This SILAC labeling based co-culture system allowed 
us to distinguish the origin of proteins by their labeling 
status, even when they were mixed in co-culture. For 
instance, in the group of individually cultured 82T-H 
mixed with co-cultured MDA-MB-231-M and 82T-L, 
we could determine that all the heavy peptides were 
from individually cultured 82T-H cells, light peptides 
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Fig. 1 Co‑culture of breast cancer cell line with CAF. a Growth patterns of 8 primary CAF cells. Cell proliferation assays for eight CAF cells were 
recorded and plotted. Y axis: average number of O.D. 595 nm of each CAF cells after crystal violet staining. Standard error of mean (SEM) bars are 
indicated. b Fluorescent microscopic image of co‑cultured MDA‑MB‑231 (Red) with CAF 82T (Green). Bottom panel: merged image of red and 
green fluorescence. c Red fluorescence of MDA‑MB‑231 cells cultured with or without 82T was measured using a POLARstar Omega microplate 
plate reader. Student t‑test was performed for assessing statistical significance. d Phase contrast images of soft agar colony formation assays 
for individually cultured and co‑cultured MDA‑MB‑231 and 82T cells. e The number of colonies in each microscopic field (×10) was counted 
for MDA‑MD‑231 cells and MDA‑MB‑231 co‑cultured with 82T cells. Y axis: average number of colonies per 10 fields. SEM bars were plotted and 
Student t test was used for statistical analysis. f Western blot analysis using 4G10 anti‑phosphotyrosine antibody to survey the phosphotyrosine 
levels of individually cultured MDA‑MB‑231 (lane 1), 82T cells (lane 2) and co‑cultured MDA‑MB‑231 and 82T cells (lane 4). Lane 3: individually 
cultured MDA‑MB‑231 and 82T cells were lysed and then mixed for phosphotyrosine western blot analysis. Arrows indicate the alteration of tyrosine 
phosphorylation induced by co‑culture that are visible in the western blot
Page 7 of 14Wu et al. Clin Proteom  (2018) 15:21 
were from co-cultured 82T-L cells, and medium pep-
tides were from co-cultured MDA-MB-231-M. By com-
paring intensities of light peptides from co-cultured 
82T-L cells with heavy peptides from individually cul-
tured 82T-H cells (Fig.  2 right arm), we were able to 
identify the alterations in 82T CAFs due to the cross-
talk with breast tumor cells. Conversely, by comparing 
medium peptides from co-cultured MDA-MB-231-M 
cells with heavy peptides from individually cultured 
MDA-MB-231-H cells (Fig.  2 left arm), we could 
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identify the alterations in MDA-MB-231 caused by the 
crosstalk with CAFs, 82T cells.
Phosphotyrosine profiling of breast cancer cells and their 
interacting CAFs
The majority of phosphorylation events in cells are on 
serine and threonine residues of proteins with a very 
small fraction (< 1%) occurring on tyrosine residues 
[25]. However, tyrosine phosphorylation is critical in 
relaying the extracellular signals through the activation 
of receptor tyrosine kinases (RTKs) into the cells [26] 
and tyrosine kinases play a disproportionately large role 
in diseases, especially in cancer. In this study, our goal 
was to study tyrosine phosphorylation-based signaling 
transduction events that were induced by the commu-
nication between tumor epithelium cells and CAFs.
In order to globally examine the tyrosine phospho-
rylation level changes, the harvested cell lysates from 
co-cultured and individually cultured cells were trypsin 
digested, desalted and phosphotyrosine peptides were 
enriched using anti-phosphotyrosine antibody (pY100). 
The enriched peptides were analyzed using tandem 
mass spectrometry on LTQ Orbitrap Velos interfaced 
with nano liquid chromatography. Mass spectrometry 
analysis identified 601 unique phosphopeptides. After 
applying phosphoRS filtering to remove ambiguously 
assigned phosphopeptides, we identified 424 phospho-
peptides corresponding to 291 proteins from two bio-
logical replicates. Among them, 364 peptides contain 
phosphorylated tyrosine, 32 peptides contain phospho-
rylated serine and 37 peptides contain phosphorylated 
threonine (Fig. 3c). The SILAC ratios (82T co-cultured 
cells versus 82T individually cultured cells and MDA-
MB-231 co-cultured cells versus MDA-MB-231 individ-
ually cultured cells) of phosphopeptides obtained from 
the two independent biological replicate experiments 
showed a positive correlation (R = 0.72 for 82T group 
and R = 0.84 for the MDA-MB-231 group) (Fig. 3a, b). 
Among the 424 phosphopeptides, 303 phosphopeptides 
from 191 proteins are identified in MDA-MB-231 cells, 
and 358 phosphopeptides from 258 proteins are iden-
tified in 82T cells, and there are 282 phosphopeptides 
shared by both types of cells (Fig.  3d). We performed 
gene ontology analysis using the online annotation 
tool DAVID [27, 28], and found that the largest class 
of the identified phosphoproteins is associated with 
the plasma membrane in both tumor epithelium and 
CAFs cells (Fig.  3e). Forty-seven proteins identified 
in 82T and 48 proteins in MDA-MB-231 cells were 
enzymes with protein kinase activity and 10 from 82T 
and 9 from MDA-MB-231 cells were receptor tyrosine 
kinases (Fig. 3f ).
Distinct signaling pathways activated in breast cancer 
epithelial cells and CAFs
In order to interrogate the regulation of protein phospho-
rylation during the co-culture, we plotted the distribution 
of phosphorylation ratios (co-cultured MDA-MB-231-M 
vs. individually cultured MDA-MB-231-H, and co-cul-
tured 82T-L vs. individually cultured 82T-H) in Fig.  4a. 
There are 51 phosphopeptides from MDA-MB-231 cells 
and 71 phosphopeptides from 82T cells that were regu-
lated by more than twofold, which could be ascribed to 
the crosstalk that occurred between the two cell types. 
Of note, the majority (around 75%) of phosphopeptides 
identified showed no change in levels during the co-cul-
ture. This validated our SILAC labeled co-culture strat-
egy that the peptide ratios can be preserved very well 
through the experimental procedures, and more impor-
tantly, the identified altered protein phosphorylation 
events are very likely to be real early events for the cross-
talk between tumor cells and CAFs. More intriguingly, 
even though about 70% of identified phosphopeptides 
were shared between both cell types, only 7 out of 122 
(~ 6%) regulated phosphotyrosine peptides were found to 
be regulated in both tumor epithelium and CAFs during 
the crosstalk. These data strongly suggest that signaling 
events that are activated by this crosstalk are very differ-
ent in MDA-MB-231 and 82T cells (Table 1).
Reciprocal activation of RTKs in breast cancer epithelial 
cells and CAFs
Our quantitative phosphoproteomic study identified 10 
receptor tyrosine kinases (RTKs), which are all known 
to be key regulators in transmitting extracellular stim-
uli into cells and initiating intracellular signaling. We 
observed that the phosphorylation level of FGFR1-Y684 
was increased 19-times in co-cultured MDA-MB-231 
cells compared to individually cultured MDA-MB-231 
cells. However, the phosphorylation level of FGFR1-
Y684 did not change in 82T cells in co-culture com-
pared to individually cultured cells (Fig.  4b). Y684 is 
located in the kinase domain of FGFR1 and is conserved 
among all FGF receptors. Y684 can be autophosphoryl-
ated upon the treatment of FGF and this autophospho-
rylation is essential for the kinase activity of FGFR1 [29]. 
Conversely, we also found that phosphorylation levels of 
EGFR Y1172 and Y1197 were dramatically elevated in 
82T cells due to the crosstalk (Fig.  4c) although EGFR 
phosphorylation levels in MDA-MB-231 were not sub-
stantially altered. Both tyrosine sites, Y1172 and Y1197, 
are in the C-terminal autophosphorylation domain of 
EGFR. Y1172 and Y1197 are two major autophosphoryla-
tion sites of EGFR, which are critical for EGFR to induce 
ERK signaling through recruitment of SHC and GRB2 
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[30, 31]. These data point to a paracrine signal transduc-
tion between CAFs and tumor epithelium in that FGFs 
secreted by CAFs can activate FGFR expressed on tumor 
epithelial cells, and EGF secreted by tumor cells can, in 
turn, activate EGFR on CAFs. Additionally, we detected 
phosphorylated RTKs including PDGFRA and IGF1R in 
82T cells co-cultured with MDA-MB-231 cells and AXL 
in MDA-MB-231 cells co-cultured with 82T cells. How-
ever, the phosphorylation of these RTKs was not detected 
in individually cultured 82T or MDA-MB-231 cells 
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(Table  1). These are excellent examples demonstrating 
the existence of paracrine crosstalk between tumor epi-
thelium and CAFs.
In addition to the RTKs activated on only one type of 
interacting cells, we also found an interesting case to 
illustrate the use of this novel system for the detection of 
mutual activation of RTKs induced by physical contact 
between tumor epithelium and CAF cells. We observed 
hyperphosphorylation of EPHA2 on tyrosine 588 in co-
cultured MDA-MB-231 cells and tyrosine 594 and 772 in 
co-cultured 82T cells (Table 1). Y588 and Y594 reside in 
the juxtamembrane region and Y772 resides in the kinase 
domain of EPHA2. They are the major autophosphoryla-
tion sites of activated EPHA2 and play important roles in 
recruiting multiple signaling adaptor proteins including 
Vav2/3 GEFs, p85 and Grb7 [32, 33]. Unlike most other 
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Table 1 List of upregulated pY peptides in response to the intercellular crosstalk
Phosphopeptide Gene symbol Protein name 82T co‑culture 
versus individually 
cultured 82T
231 co‑culture 
versus individually 
cultured 231
ASAyYPSSFPK TMEM119 Transmembrane protein 119 Only in Co‑cultured
CCCIyEKPR PPP1R11 Protein phosphatase 1, regulatory 
(inhibitor) subunit 11
Only in Co‑cultured 0.36
DIYETDyYRK IIGF1R Insulin receptor|| insulin‑like growth 
factor 1 receptor
Only in Co‑cultured
FGyHIIMVEGR PIN4 Peptidylprolyl cis/trans isomerase, 
NIMA‑interacting 4
Only in Co‑cultured
GASQAGMtGYGRPR TAGLN Transgelin Only in Co‑cultured
GIVVyTGDR ATP1A1 ATPase, Na +/K + transporting, alpha 1 
polypeptide
Only in Co‑cultured
GKSDPyHATSGALSPAK GJA1 Gap junction protein, alpha 1, 43 kDa Only in Co‑cultured
GSTAENAEyLR EGFR Epidermal growth factor receptor Only in Co‑cultured 1.94
IEKIGEGtyGVVYK CDK1 Cyclin‑dependent kinase 1 Only in Co‑cultured
IGEGTYGVVyKGR CDK1 Cyclin‑dependent kinase 1 Only in Co‑cultured 0.91
IGEGTyGVVYKGR CDK1 Cyclin‑dependent kinase 1 Only in Co‑cultured 1.00
IGVVGGCQEyTGAPYFAAISALK CARKD Carbohydrate kinase domain contain‑
ing
Only in Co‑cultured
LVQAAQMLQSDPYsVPAR VCL Vinculin Only in Co‑cultured
NTPyKTLEPVKPPTVPNDYMTSPAR ABI1 Abl‑interactor 1 Only in Co‑cultured
NVPEIAVYPAFEAPPQYVLPTyEMAVK LAPTM4A Lysosomal protein transmembrane 
4 alpha
Only in Co‑cultured
NVPEIAVYPAFEAPPQYVLPtYEMAVK LAPTM4A Lysosomal protein transmembrane 
4 alpha
Only in Co‑cultured
QASEQNWANySAEQNR GJA1 Gap junction protein, alpha 1, 43 kDa Only in Co‑cultured
QPAPKPEPSFSEYAsVQVPR SIRPA Signal‑regulatory protein alpha Only in Co‑cultured
QPAPKPEPSFSEyASVQVPR SIRPA Signal‑regulatory protein alpha Only in Co‑cultured
QQPTQFINPETPGyVGFANLPNQVHR SPET2 Septin 2 Only in Co‑cultured
QSPEDVyFSKSEQLKPLK EPHA2 EPH receptor A2 Only in Co‑cultured 0.95
SLyDRPASyKK PDGFRA Platelet‑derived growth factor recep‑
tor, alpha polypeptide
Only in Co‑cultured
VVQEYIDAFSDyANFK PTPRA Protein tyrosine phosphatase, receptor 
type, A
Only in Co‑cultured 1.06
YEMASNPLyR ITGB5 Integrin, beta 5 Only in Co‑cultured
TYVDPHTyEDPNQAVLK EPHA2 EPH receptor A2 6.60 1.29
KTPQGPPEIySDTQFPSLQSTAK CDV3 CDV3 homolog (mouse) 5.16 0.51
GSHQISLDNPDyQQDFFPK EGFR Epidermal growth factor receptor 4.16 0.93
IGEGTYGVVyK CDK3|| CDK2|| CDK1 Cyclin‑dependent kinase1,2,,3 4.04 1.20
EATQPEPIyAESTK SGK223 Homolog of rat pragma of Rnd2__ 3.22 0.95
IGEGTyGVVYK CDK3|| CDK2|| CDK1 Cyclin‑dependent kinase1,2,,3 3.04
IEKIGEGtYGVVYK CDK1 Cyclin‑dependent kinase 1 2.99
STLQDSDEySNPAPLPLDQHSR LPXN Leupaxin 2.86
IEKIGEGTyGVVYK CDK1 Cyclin‑dependent kinase 1 2.82
IGEGTyGTVFK CDK5 Cyclin‑dependent kinase 5 2.77 0.79
VLEDDPEATyTTSGGKIPIR EPHA2 EPH receptor A2 2.29 1.30
NSFNNPAyYVLEGVPHQLLPPEPPSPAR INPPL1 Inositol polyphosphate phosphatase‑
like 1
2.28 0.00
TTEDEVHICHNQDGySYPSR LDLR Low density lipoprotein receptor 2.24 1.67
NTyNQTALDIVNQFTTSQASR CASKIN2 CASK interacting protein 2 2.09 1.27
AGKGESAGyMEPYEAQR SHB Src homology 2 domain containing 
adaptor protein B
Only in Co‑cultured
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RTKs, both ligands and receptors for EPH family mem-
bers are membrane-bound proteins (transmembrane or 
GPI-anchored) [34, 35]. The activation of EPHA2 in both 
CAF and epithelial tumor cells suggests a physical con-
tact between CAFs and epithelial tumor, and such find-
ings can be revealed using a SILAC-based co-culture 
system but not by a conventional conditioned medium 
system.
Besides identification of reciprocally activated RTKs, 
our analysis also revealed elevated phosphorylation levels 
of a G protein-coupled receptor, GPRC5A, on tyrosine 
350 located in its C-terminal tail. Indeed, this tyrosine 
residue in GPRC5A has been shown to be phosphoryl-
ated by RTKs including EGFR to suppress its tumor sup-
pressor function [36]. In our study, we found Y350 of 
GPRC5A was hyperphosphorylated in co-cultured MDA-
MB-231 cells.
Besides increased phosphorylation level of many 
transmembrane proteins, we also observed that multi-
ple cyclin dependent kinase (CDK) proteins were hyper-
phosphorylated in CAFs through the contact with tumor 
cells (Table  1). This suggests dramatic cell cycle altera-
tions in CAFs, which is in line with published literature 
showing that co-culturing CAFs with MDA-MB-231 
cells can accelerate CAF cell proliferation [3, 37]. More 
intriguingly, we discovered, for the first time, that inter-
action between CAFs and MDA-MB-231 cells could 
greatly induce hyperphosphorylation of STAT3 and 
PTPN11/SHP2 (Table 1). Both of these proteins play piv-
otal roles in mediating cell survival and transformation 
[38, 39] as well in developing resistance to EGFR inhibi-
tors [40, 41]. Additionally, several non-receptor kinases 
and phosphatases such as PRKCD, PPP1R11, CRKL and 
PTPRA4 were identified for the first time as implicated 
in the crosstalk between CAFs and tumor epithelial cells 
(Table 1).
Discussion
Communication and interaction between cells is essen-
tial for tissue homeostasis and frequently dysregulated in 
cancers. Although there is great progress in technology 
development to unravel the intracellular signaling net-
works using monolayer cell culture models, our ability 
to biochemically decipher the crosstalk between cells in 
direct contact remains limited. This is mainly because it 
is technically difficult to distinguish cell-specific proteins 
when different types of cells are mixed in co-culture and 
processed together. To achieve this goal, we employed a 
quantitative proteomic strategy by integrating SILAC 
labeling method with the classical co-culture model 
Table 1 (continued)
Phosphopeptide Gene symbol Protein name 82T co‑culture 
versus individually 
cultured 82T
231 co‑culture 
versus individually 
cultured 231
AHAWPSPYKDyEVKK GPRC5A G protein‑coupled receptor, class C, 
group 5, member A
Only in Co‑cultured
DKVTIADDySDPFDAKNDLK SHB Src homology 2 domain containing 
adaptor protein B
Only in Co‑cultured
GRGEyFAIK PRKCD Protein kinase C, delta Only in Co‑cultured
GySFTTTAER ACTG1|| ACTB Actin gamma 1|| actin, beta Only in Co‑cultured
HTDDEMTGYVAtR MAPK14 Mitogen‑activated protein kinase 14 Only in Co‑cultured
LDTASSNGYQRPGsVVAAK ARHGAP42 Rho GTPase activating protein 42 Only in Co‑cultured
LKQPADCLDGLyALMSR AXL AXL receptor tyrosine kinase Only in Co‑cultured
NIySDIPPQVPVRPISYTPSIPSDSR FAT1 FAT atypical cadherin 1 Only in Co‑cultured
NNYALNTTA TYA EPYRPIQyR PKP4 Plakophilin 4 Only in Co‑cultured
YLNRNyWEK HGS Hepatocyte growth factor‑regulated 
tyrosine kinase substrate
Only in Co‑cultured
DIHHIDyYKK FGFR1 Fibroblast growth factor receptor 1 0.98 19.26
YCRPESQEHPEADPGSAAPyLK STAT3 Signal transducer and activator of 
transcription 3
0.98 7.03
SEQLKPLKTyVDPHTYEDPNQAVLK EPHA2 EPH receptor A2 5.60
YCRPESQEHPEADPGAAPyLK STAT3 Signal transducer and activator of 
transcription 3
0.86 4.89
NSNSYGIPEPAHAyAQPQTTTPLPAVs‑
GSPGAAITPLPSTQNGPVFAK
CRKL v‑crk avian sarcoma virus CT10 onco‑
gene homolog‑like
2.49
STyTSYPK HGS Hepatocyte growth factor‑regulated 
tyrosine kinase substrate
1.46 2.33
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system coupled with mass spectrometry-based phospho-
proteomic profiling to systematically and quantitatively 
explore signaling mechanisms underlying the crosstalk 
between tumor epithelium and CAFs. With this strategy, 
we were able to distinguish sources of individual proteins 
from tumor cells or CAFs even after they were mixed for 
co-culture and lysed together.
Using this approach, we showed that the crosstalk 
between CAFs and tumor cells can induce tyrosine phos-
phorylation of different signaling proteins in CAFs or 
in tumor cells. We demonstrated that the crosstalk can 
reciprocally activate multiple RTKs in CAFs and tumor 
cells. Particularly, we were able to detect unique activa-
tion of EGFR and IGF1R in CAF cells due to the commu-
nication with tumor cells. We also detected FGFR1 and 
AXL activation in tumor cells resulting from the com-
munication with CAFs [42]. A recent study showed that 
CAF-derived GAS6, an AXL ligand, can activate AXL 
and promote tumor cells migration. More importantly, 
we also discovered that the crosstalk could bi-direction-
ally activate EPHA2 in both tumor cell and CAFs, sug-
gesting the direct physical interaction between CAFs and 
MDA-MB-231 cells. In addition to these RTKs, a number 
of downstream non-receptor kinases and adaptor pro-
teins were also shown to be regulated by the crosstalk. 
These results indicate that not only cellular membrane 
receptors such as RTKs but also downstream signaling 
molecules are activated by the crosstalk.
Conclusions
In this study, we used a rapidly growing CAF co-cul-
tured with an aggressive triple negative breast cancer 
cell line as a model system to investigate the crosstalk 
signaling between these two types of cells. However, 
this is the first study using SILAC coupled with mass 
spectrometry-based proteomics to decode the bi-direc-
tional phosphorylation signaling events between breast 
cancer cells and their interacting primary CAFs. We 
believe the knowledge obtained from our exploratory 
study will not only facilitate the understanding of how 
CAFs co-evolve with tumor cells and in-turn enhance 
tumor aggressiveness, but also will help to develop 
novel therapeutic approaches to effectively disrupt the 
crosstalk between CAFs and tumor cells and suppress 
tumor growth. Finally, this model system could be used 
as a prototype for the analysis of intercellular crosstalk 
in many different tumor microenvironments, which 
will greatly benefit the understanding of tumor biology 
and ultimately accelerate the eradication of cancers.
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